Plain-English translation of NCT07528014 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting real-world treatment data from people being treated for depressed mood with one of three therapies: esketamine, transcranial magnetic stimulation (TMS), or Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). Researchers want to use this information to build predictive tools that could one day help doctors match each patient with the treatment most likely to help them.
Right now, doctors don't have reliable ways to predict which depression treatment will work best for a specific person—so patients sometimes have to try multiple therapies before finding relief. This study aims to solve that problem by collecting data that could enable personalized treatment selection.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your regular depression treatment (whichever one your doctor prescribed) while the study collects and tracks your clinical information and outcomes. Researchers will gather data from your visits and may use information from your existing medical records to help build their predictive models. The study involves 5,000 participants total, so you would be contributing to a large real-world dataset designed to improve treatment matching for future patients.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States